Resumen | What is already known about this topic? Clinical trials have demonstrated the efficacy of COVID-19 vaccines in a controlled setting. Israel initiated a national vaccination campaign in December 2020, prioritizing persons aged >60 years and other high-risk populations. What is added by this report? By February 2021, 2-dose vaccination coverage was 84% among persons aged ≥70 years and 10% among those aged What are the implications for public health practice? These findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 at the national level in Israel. |
---|---|
Procedencia del autor |
Texto completo |
---|
Tipo de documento | |
---|---|
Especialidad(es) |
Publicado en el sitio | 2021-03-10 11:45:51 |
---|
(aún no hay comentarios disponibles para este recurso)
Comentarios